Clinical Trial: The study of Immunogenicity and Safety of Simplified 4-Dose Regimen of Freeze-Dried Human Rabies Vaccine (Vero Cell) in Populations Post-Rabies Exposure (China)

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The study of Immunogenicity and Safety of Simplified 4-Dose Regimen of Freeze-Dried Human Rabies Vaccine (Vero Cell) in Populations Post-Rabies Exposure'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131150

Registration Time: 2026/08/28

Type: Observational study

Primary Sponsor: Guangzhou Eighth Peoples Hospital Guangzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337715

Published by HT Digital Content Services with permission from Health Daily Digest....